Joint Ministerial Decision includes pharmaceutical R&D projects and investment plans expenses to the clawback set-off

On February 7, 2020, the Minister of Finance, the Minister of Health and the Minister of Development and Investments issued the Joint Ministerial Decision (JMD) B1.B2/4577/2020 OGG 380/B/7-2-2020 on the issue: “Process, terms and conditions for the clawback set-off of the pharmaceutical expenses against rates of research and development expenses and expenses for investment plans for product or services or production lines development – Determination of the maximum amount for the expenses of 2019”. This came as no surprise because the JMD in question implements art. 20 of Law 4633/2019, voted by the Greek Parliament on November, 2019, providing the aforementioned Ministers with the relevant legislative delegation power to issue such a decision.

Download pdf